adjuv
enhanc
vaccin
immunogen
induc
longterm
enhanc
immun
respons
thu
adjuv
import
vaccin
research
polysaccharid
isol
select
chines
herb
demonstr
possess
variou
benefici
function
excel
adjuv
abil
present
studi
polysaccharid
isol
isati
indigotica
root
compar
common
vaccin
adjuv
aluminum
hydroxid
via
intramuscular
coadministr
inactiv
rabi
viru
mice
blood
collect
determin
viru
neutral
antibodi
vna
titer
b
lymphocyt
activ
statu
inguin
lymph
node
sampl
collect
use
measur
b
lymphocyt
prolifer
splenocyt
isol
antigenspecif
cellular
immun
respons
detect
via
elispot
elisa
intracellular
cytokin
stain
result
reveal
type
polysaccharid
induc
rapid
chang
higher
vna
titer
aluminum
hydroxid
flow
cytometri
assay
reveal
polysaccharid
activ
b
lymphocyt
lymph
node
b
lymphocyt
blood
aluminum
hydroxid
antigenspecif
cellular
immun
respons
show
strongli
induc
lymphocyt
prolifer
spleen
high
level
cytokin
secret
splenocyt
wherea
aluminum
hydroxid
induc
prolifer
small
number
lymphocyt
secret
small
quantiti
cytokin
collect
data
suggest
polysaccharid
exhibit
excel
adjuv
activ
enhanc
cellular
humor
immun
rabi
fatal
form
encephalomyel
caus
rabi
viru
warmblood
anim
includ
human
suscept
accord
world
health
organ
approxim
peopl
die
rabi
year
worldwid
total
includ
peopl
china
china
second
worldwid
term
number
rabiesrel
death
mortal
rate
rabi
nearli
clinic
symptom
appear
effect
way
prevent
spread
rabi
inocul
vaccin
previou
studi
shown
domest
dog
respons
human
rabi
case
immun
domest
dog
may
suffici
prevent
rabi
transmiss
human
avoid
rabi
epidem
commerci
rabi
vaccin
human
veterinari
use
china
inactiv
cell
cultur
vaccin
inactiv
cell
cultur
vaccin
safe
easi
use
store
howev
least
inject
requir
provid
suffici
viru
neutral
antibodi
vna
titer
least
iuml
reliabl
indic
immun
protect
rabi
viru
infect
achiev
fact
rabi
neutral
antibodi
titer
reliabl
indic
immun
protect
previou
studi
shown
nearli
onethird
dog
receiv
one
inject
commerci
rabi
vaccin
fail
produc
vna
titer
iuml
use
multipl
inject
translat
higher
cost
therefor
becom
unafford
develop
countri
similar
circumst
exist
human
human
rabi
vaccin
given
postexposur
http
elsevi
bv
right
reserv
rapid
gener
antibodi
respons
follow
rabi
vaccin
import
current
postexposur
prophylaxi
schedul
requir
least
inject
effect
rabi
immun
globulin
requir
seriou
case
vaccin
adjuv
wide
use
acceler
boost
immun
respons
aluminum
hydroxid
commonli
use
vaccin
adjuv
howev
contribut
earli
antibodi
respons
limit
may
caus
side
effect
case
addit
studi
shown
aluminum
hydroxid
may
even
delay
earli
antibodi
product
interestingli
previou
record
chines
pharmacopoeia
describ
use
aluminum
hydroxid
human
rabi
vaccin
delet
fifth
edit
therefor
novel
adjuv
must
develop
increas
effect
inactiv
rabi
veterinari
vaccin
provid
better
immun
coverag
domest
dog
turn
help
block
rabi
transmiss
human
approv
human
use
could
reduc
dose
schedul
requir
postexposur
prophylaxi
recent
research
shown
mani
plant
polysaccharid
specif
deriv
chines
herb
enhanc
immunogen
use
promot
humor
cellular
immun
polysaccharid
natur
safe
nonresidu
use
isati
indigotica
root
medicin
china
trace
back
begin
common
era
believ
root
stimul
bodi
resist
influenza
sever
acut
respiratori
syndrom
sar
may
even
prevent
condit
polysaccharid
alphaglucan
isol
root
indigotica
chemic
structur
adjuv
activ
influenza
hepat
b
surfac
antigen
hbsag
vaccin
describ
previou
studi
anoth
polysaccharid
isol
root
arabinogalactan
molecular
weight
da
compos
arabinos
galactos
ratio
structur
activ
adjuv
previous
describ
previou
studi
also
shown
arabinogalactan
use
either
potenti
immun
respons
adjuv
human
anim
vaccin
present
studi
evalu
use
polysaccharid
adjuv
inactiv
rabi
viru
vaccin
mice
effect
antigenspecif
humor
cellular
immun
respons
protect
capac
challeng
virul
rabi
viru
also
analyz
rabi
viru
provid
chines
center
diseas
control
prevent
recombin
viru
recov
store
laboratori
previous
describ
street
rabi
viru
strain
isol
pig
hunan
provinc
store
laboratori
strain
propag
bsr
cell
grown
dulbecco
modifi
eagl
minimum
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
bsr
cell
infect
moi
titer
viru
collect
tissu
cultur
infecti
dose
unit
tcid
ml
inactiv
mix
mixtur
incub
overnight
c
h
c
inactiv
mix
incub
overnight
c
aluminum
hydroxid
mix
complet
inactiv
volumetr
ratio
mice
randomli
divid
group
mice
per
group
inocul
twice
l
inactiv
tcid
mix
differ
adjuv
interv
control
group
inject
twice
l
inactiv
tcid
mock
group
inject
twice
pb
time
point
dose
g
either
includ
mice
challeng
intramuscular
mous
lethal
dose
imld
street
rabi
viru
strain
inject
forelimb
muscl
day
first
immun
follow
mice
observ
addit
day
observ
period
mice
develop
clinic
sign
rabi
human
euthan
cervic
disloc
isofluran
anesthesia
blood
collect
mice
day
first
immun
retroorbit
plexu
punctur
mice
group
randomli
select
time
point
repres
mean
vna
titer
vna
titer
determin
use
fluoresc
antibodi
viru
neutral
favn
test
spleen
collect
mice
group
day
second
vaccin
splenocyt
isol
suspend
concentr
ml
rpmi
medium
supplement
fb
splenocyt
suspens
stimul
inactiv
concentr
gml
cell
suspens
incub
c
h
number
cell
produc
interferon
ifn
interleukin
il
splenocyt
measur
use
enzymelink
immunospot
elispot
assay
mous
elispot
kit
mabtech
ab
stockholm
sweden
accord
manufactur
instruct
number
spotform
cell
sfc
determin
use
autom
elispot
reader
aid
gmbh
strasberg
germani
splenocyt
isol
mice
group
day
second
immun
splenocyt
suspens
cellsml
prepar
rpmi
medium
contain
fb
splenocyt
suspens
stimul
inactiv
concentr
gml
cultur
protein
transport
inhibitor
contain
monensin
bd
bioscienc
franklin
tn
usa
c
cell
suspens
product
rabiesspecif
antibodi
mice
follow
administr
mix
differ
adjuv
adjuv
control
mice
immun
twice
intramuscular
inject
hind
leg
interv
blood
collect
randomli
select
mice
group
day
first
immun
rabiesspecif
antibodi
titer
measur
use
favn
test
repres
data
shown
mean
sd
mice
group
analyz
use
oneway
anova
p
p
collect
h
cell
surfacestain
antimous
antimous
antibodi
bd
bioscienc
min
c
cell
permeabil
min
c
cytofixcytoperm
bd
bioscienc
stain
antimous
antimous
antibodi
bd
bioscienc
min
c
stain
cell
analyz
use
flow
cytomet
inguin
lymph
node
sampl
harvest
mice
group
day
first
immun
cell
isol
singlecel
suspens
prepar
phosphatebuff
salin
pb
stain
min
c
antibodi
bd
bioscienc
label
b
cell
stain
cell
wash
twice
pb
analyz
use
flow
cytomet
wholeblood
sampl
collect
mice
group
day
primari
immun
retroorbit
plexu
punctur
peripher
blood
mononuclear
cell
pbmc
isol
singlecel
suspens
cellsml
prepar
pb
cell
stain
min
c
antimous
bd
bioscienc
label
b
cell
monoclon
antibodi
bd
bioscienc
label
cell
label
cell
wash
twice
pb
analyz
use
flow
cytomet
splenocyt
isol
mice
group
day
first
vaccin
suspend
rpmi
medium
contain
fb
concentr
cellsml
splenocyt
suspens
stimul
inactiv
final
concentr
gml
incub
c
supernat
suspens
collect
h
poststimul
measur
use
enzymelink
immunosorb
assay
elisa
mous
elisa
kit
mabtech
ab
accord
manufactur
instruct
mice
divid
group
mice
per
group
challeng
imld
street
rabi
viru
strain
muscl
forelimb
twentyfour
hour
challeng
mice
immun
tcid
mix
differ
adjuv
alhydrogel
mock
group
inject
pb
group
immun
twice
h
challeng
mice
observ
day
mice
develop
clinic
sign
rabi
observ
period
human
euthan
cervic
disloc
isofluran
anesthesia
data
express
mean
standard
deviat
sd
statist
analys
perform
use
spss
softwar
spss
inc
chicago
il
usa
determin
statist
signific
differ
gener
data
oneway
analysi
varianc
anova
statist
signific
differ
survivor
ratio
determin
kaplanmei
analysi
result
consid
signific
p
signific
p
blood
collect
determin
antibodi
titer
predetermin
time
immun
fig
show
mean
vna
titer
rabi
viru
mice
immun
mix
differ
adjuv
none
antibodi
titer
rose
iuml
day
first
immun
titer
mice
immun
vaccin
addit
rose
iuml
day
first
immun
mean
vna
titer
four
group
rose
iuml
day
first
immun
second
immun
done
collect
blood
fourteenth
day
primari
immun
antibodi
titer
mice
two
polysaccharid
test
group
higher
alhydrogel
group
vna
titer
mice
mock
group
rise
iuml
data
shown
fig
confirm
studi
polysaccharid
could
enhanc
vna
respons
mice
use
elispot
assay
detect
antigenspecif
activ
splenocyt
shown
fig
elispot
analysi
secret
ic
assay
antigenspecif
cell
secret
mous
splenocyt
spleen
collect
mice
per
group
day
second
vaccin
splenocyt
assay
elispot
ic
assay
sfc
secret
b
measur
use
commerci
elispot
kit
rabvspecif
cell
measur
via
ic
assay
spleen
collect
mice
per
group
day
second
vaccin
stain
mous
monoclon
antibodi
cell
secret
c
cell
secret
e
f
shown
fig
data
repres
subtract
valu
mean
sd
mice
analyz
use
oneway
anova
p
p
p
fig
b
greater
number
sfc
mice
inject
mice
group
also
analyz
capac
adjuv
induc
secret
cell
intracellular
cytokin
stain
ic
shown
fig
f
induc
greater
number
cell
adjuv
test
similar
result
also
observ
cell
fig
e
result
group
show
signific
differ
investig
whether
polysaccharid
function
adjuv
induc
b
cell
activ
lymph
node
collect
mice
cell
isol
collect
lymph
node
analyz
flow
cytometri
shown
fig
b
number
activ
b
cell
lymph
node
significantli
higher
group
fig
flow
cytometri
analysi
b
cell
isol
lymph
node
lymph
node
collect
mice
per
group
cultur
describ
section
differ
adjuv
activ
b
cell
b
day
first
immun
repres
data
shown
mean
sd
mice
per
group
analyz
use
oneway
anova
p
p
alhydrogel
group
day
first
immun
repres
scatter
plot
b
cell
lymph
node
day
post
first
immun
shown
fig
b
investig
use
polysaccharid
adjuv
blood
collect
pbmc
isol
cultur
stain
describ
result
cell
suspens
analyz
flow
cytometri
fig
b
show
cell
recruit
fig
show
b
cell
activ
blood
activ
greatest
number
b
cell
among
four
test
adjuv
condit
fig
b
show
repres
scatter
plot
cell
b
cell
blood
level
cytokin
secret
splenocyt
measur
use
commerci
elisa
kit
shown
fig
level
secret
splenocyt
isol
mice
group
significantli
higher
detect
experiment
group
fig
c
level
polysaccharid
group
higher
mock
alhydrogel
group
evalu
whether
immun
respons
induc
administr
inactiv
mix
polysaccharid
could
provid
protect
rabi
infect
mice
challeng
street
rabi
viru
strain
mice
polysaccharid
group
surviv
wherea
one
mous
aluminum
hydroxid
group
three
mice
control
group
none
mice
pb
group
surviv
result
challeng
test
shown
fig
clinic
symptom
rtpcr
result
produc
assess
total
rna
brain
tissu
collect
dead
mice
reveal
mice
die
rabi
infect
data
shown
result
challeng
test
suggest
provid
complet
protect
street
rabi
viru
infect
mix
inactiv
rabi
vaccin
determin
protect
effect
polysaccharid
adjuv
postexposur
prophylaxi
mice
challeng
h
immun
one
mous
aluminum
hydroxid
group
surviv
challeng
contrast
mice
group
mice
group
surviv
durat
observ
period
wherea
mice
mock
group
die
fig
clinic
symptom
rtpcr
result
produc
assess
total
rna
isol
brain
tissu
collect
dead
mice
indic
mice
die
rabi
infect
data
shown
due
safeti
concern
human
rabi
vaccin
use
today
inactiv
viru
vaccin
although
vaccin
safe
induc
mild
immun
respons
therefor
requir
multipl
inject
gener
antibodi
product
proce
slow
rate
postexposur
immun
main
immun
method
use
human
incub
period
rabi
short
one
week
rabi
immun
globulin
need
sever
case
recommend
dose
equin
rabi
immun
globulin
iukg
translat
need
iu
iu
equin
immun
globulin
per
individu
word
least
vial
dose
rabi
immun
globulin
requir
per
case
cost
treatment
regim
bare
afford
inhabit
develop
countri
cost
one
dose
equin
rabi
immun
globulin
cambodia
develop
countri
southeast
asia
rang
us
us
far
expens
farmer
live
rural
area
cambodia
whose
monthli
incom
typic
less
us
although
dose
recommend
human
rabi
immun
globulin
hrig
iukg
cost
hrig
even
expens
postexposur
prophylaxi
may
also
fail
insuffici
immun
globulin
use
immun
globulin
use
improperli
scenario
occur
develop
countri
lack
skill
physician
thu
high
cost
rabi
immun
globulin
improv
antibodi
product
rate
critic
gener
postexposur
rabi
vaccin
effect
human
use
especi
develop
countri
adjuv
acceler
gener
antibodi
respons
induc
cellular
immun
would
optim
aluminum
hydroxid
tradit
wide
use
adjuv
stimul
immun
respons
induc
respons
prolong
exposur
antigen
immun
system
delay
antigen
clearanc
immun
site
mechan
contribut
slightli
earli
antibodi
respons
cellular
immun
furthermor
side
effect
sever
inflammatori
nervou
system
concern
may
appear
certain
case
polysaccharid
emerg
new
type
adjuv
use
stimul
rapid
immun
respons
therebi
serv
highli
valuabl
vaccin
addit
although
wellknown
immun
respons
stimul
studi
report
also
use
adjuv
purpos
human
veterinari
vaccin
molecular
weight
kda
isol
tinospora
cordifolia
shown
activ
lymphocyt
vitro
stimul
secret
tumor
necrosi
factor
tnf
secret
molecular
weight
da
evalu
current
studi
capac
serv
immun
stimul
accomplish
splenocyt
isol
cultur
vitro
level
secret
assess
three
case
secret
significantli
enhanc
p
p
p
also
measur
rabiesspecif
vna
titer
import
gaug
effect
rabi
vaccin
found
mice
receiv
vaccin
adjuv
significantli
higher
vna
titer
rabi
viru
mice
receiv
aluminum
hydroxid
day
postimmun
p
p
cellular
immun
also
play
import
role
resist
rabi
infect
may
clear
rabi
viru
cn
cell
deriv
cell
secret
type
cytokin
possess
antivir
activ
stimul
cell
prolifer
addit
cell
also
deriv
cell
secret
type
cytokin
induc
helper
activ
b
cell
stimul
humor
immun
respons
cytokin
profil
indic
mediat
immun
via
pathway
mediat
immun
via
pathway
arabinogalactan
highli
branch
polysaccharid
easili
dissolv
water
molecul
high
molecular
weight
consist
larabinos
dgalactos
moieti
sever
studi
shown
adjuv
activ
arabinogalactan
larg
depend
molecular
weight
chemic
structur
polysaccharid
chain
conform
resistaid
tm
arabinogalactan
product
isol
larch
plant
highli
branch
structur
backbon
compos
arabinos
galactos
unit
volumetr
ratio
adjuv
qualiti
relat
igg
product
test
oral
doubleblind
parallelgroup
studi
evalu
pneumococc
vaccin
sign
toxic
side
effect
observ
resistaid
tm
use
dose
gday
week
healthi
volunt
larch
plant
arabinogalactan
also
appear
low
toxic
side
effect
sign
toxic
appar
either
mice
rat
administ
dose
either
gkg
mgkg
month
current
studi
anoth
arabinogalactan
isol
root
indigotica
evalu
possess
backbon
similar
found
larch
arabinogalactan
adjuv
qualiti
assess
use
inact
rabi
viru
first
measur
rabiesspecif
antibodi
respons
import
indic
vaccin
efficaci
result
favn
test
show
mice
treat
significantli
higher
vna
titer
mice
treat
aluminum
hydroxid
second
vaccin
p
p
p
studi
report
arabinogalactan
enhanc
effect
cellular
immun
respons
exampl
arabinogalactan
isol
cordifolia
chemic
structur
similar
shown
activ
bone
marrowderiv
dendrit
cell
bmdc
vitro
spleen
dendrit
cell
vivo
secret
cytokin
bmdc
cell
stimul
also
increas
current
studi
evalu
antigenspecif
cellular
immun
respons
elispot
ic
result
indic
activ
spleen
cell
stimul
secret
find
suggest
mediat
immun
respons
though
pathway
flow
cytometri
analysi
show
mice
treat
higher
number
activ
b
lymphocyt
blood
lymph
node
control
mice
result
challeng
postexposur
immun
test
show
mix
could
protect
mice
challeng
lethal
street
rabi
viru
strain
polysaccharid
analyz
current
studi
particularli
enhanc
antigenspecif
cellular
immun
respons
spleen
cell
activ
cell
promot
cytokin
secret
contrast
aluminum
hydroxid
significantli
affect
either
spleen
cell
lymphocyt
togeth
result
suggest
polysaccharid
evalu
significantli
enhanc
cellular
immun
respons
acceler
antibodi
respons
inactiv
rabi
vaccin
enhanc
b
lymphocyt
prolifer
increas
cytokin
secret
may
princip
mechan
enhanc
achiev
aluminum
hydroxid
could
induc
slow
antibodi
respons
includ
secret
cytokin
thu
result
suggest
plant
root
polysaccharid
may
effect
improv
antibodi
respons
tradit
adjuv
use
conjunct
inactiv
rabi
vaccin
increas
effect
acceler
immun
protect
reduc
requir
vaccin
dosag
overal
result
indic
polysaccharid
test
studi
particular
use
adjuv
conjunct
inactiv
rabi
vaccin
induc
robust
immun
respons
anim
potenti
human
conclus
work
highlight
potenti
use
polysaccharid
develop
afford
postexposur
vaccin
use
human
